Field | Row 1 |
---|---|
adsh | 0001641172-25-010345 |
cik | 890821 |
name | ENVERIC BIOSCIENCES, INC. |
sic | 2834 |
countryba | US |
stprba | FL |
cityba | NAPLES |
zipba | 34103 |
bas1 | 4851 TAMIAMI TRAIL N, SUITE 200 |
bas2 | |
baph | 239-302-1707 |
countryma | US |
stprma | FL |
cityma | NAPLES |
zipma | 34103 |
mas1 | 4851 TAMIAMI TRAIL N, SUITE 200 |
mas2 | |
countryinc | US |
stprinc | DE |
ein | 954484725 |
former | AMERI HOLDINGS, INC. |
changed | 20150527 |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250514 |
accepted | 2025-05-14 17:00:00.0 |
prevrpt | 0 |
detail | 1 |
instance | form10-q_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001641172-25-010345 | 20250331 | Accounts Payable And Other Accrued Liabilities Current | 413837.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 193848.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Assets | 5102119.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Cash | 4294435.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Common Stock Shares Outstanding | 678002.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Earnings Per Share Diluted | -1.2200 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 202397.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Interest Paid Net | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Net Offering Costs | 12821.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20240331 | Operating Costs And Expenses | 2477317.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Other Liabilities Current | 101375.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
0001641172-25-010345 | 20250331 | Payments Of Stock Issuance Costs | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20250331 | Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Research And Development Expense | 506155.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Shares Outstanding | 2471656.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20231231 | Stockholders Equity | 1827.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued1 | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Stock Issued During Period Shares Issued Direct Offering Net Of Offering Cost | 15246.0000 | shares | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Shares New Issues | 1229330.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | 1112.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | USD | 1 | 0001641172-25-010345 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Other | 1537140.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Round Up | USD | 1 | 0001641172-25-010345 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 1797774.0000 | shares | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Assets Current | 4834840.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Common Stock Shares Issued | 2471656.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Depreciation | 38842.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Earnings Per Share Diluted | -9.2100 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Gain Loss On Investments | 1707.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2184966.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Liabilities And Stockholders Equity | 5102119.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Net Cash Provided By Used In Operating Activities | -2391582.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 17906.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20240331 | Proceeds From Issuance Of Warrants | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Proceeds From Warrant Exercises | 75044.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Research And Development Expense | 746371.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Shares Outstanding | 486272.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20231231 | Stockholders Equity | -569749.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001641172-25-010345 | 20240331 | Stockholders Equity | -551843.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001641172-25-010345 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Stockholders Equity | 3917713.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Shares Exercise Of Inducement Warrants For Common Stock | 130267.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | USD | 1 | 0001641172-25-010345 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | USD | 1 | 0001641172-25-010345 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value New Issues | 4232174.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20241231 | Temporary Equity Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Temporary Equity Shares Authorized | 100000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 1797774.0000 | shares | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Accounts Payable Current | 521747.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -594517.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -598004.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Additional Paid In Capital | 112750472.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20240331 | Amortization Of Intangible Assets | 42188.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Cash | 2800000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Other Consulting And Vendor Agreements; | ||
0001641172-25-010345 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250131 | Common Stock Shares Issued | 15.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Fair Value Adjustment Of Warrants | -858.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Finite Lived Intangible Assets Net | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Increase Decrease In Due To Related Parties | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 759289.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Liabilities Current | 1184406.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Net Income Loss | -2456915.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20240331 | Operating Income Loss | -2477317.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20241231 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Preferred Stock Shares Authorized | 3600000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Retained Earnings Accumulated Deficit | -106074505.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20231231 | Stockholders Equity | 1956336.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Stockholders Equity | -98956433.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001641172-25-010345 | 20250331 | Stock Issued1 | 874.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | 1808789.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | -146.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | 322301.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Round Up | 874.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Temporary Equity Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 266764.0000 | shares | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Accounts Payable And Other Accrued Liabilities Current | 735098.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Additional Paid In Capital | 108255049.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20250331 | Assets Noncurrent | 267279.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2287977.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 2053409.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250131 | Common Stock Shares Outstanding | 15.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Comprehensive Income Net Of Tax | -2439009.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Comprehensive Income Net Of Tax | -2188453.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001641172-25-010345 | 20240331 | Net Income Loss | -2456915.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001641172-25-010345 | 20240331 | Nonoperating Income Expense | 22133.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Nonoperating Income Expense | 2567.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Operating Costs And Expenses | 2187533.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Operating Income Loss | -2187533.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001641172-25-010345 | 20240331 | Other Income | 21437.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20240331 | Proceeds From Warrant Exercises | 2676980.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Share Based Compensation | 193848.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20231231 | Stockholders Equity | 100841416.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20231231 | Stockholders Equity | -1817640.0000 | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
0001641172-25-010345 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Shares Issued For Services | 462336.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | USD | 1 | 0001641172-25-010345 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | USD | 1 | 0001641172-25-010345 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value New Issues | 1854151.0000 | USD | 0 | us-gaap/2024 | Range= Maximum; Subsequent Event Type= Subsequent Event; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value New Issues | 4244467.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Other | 469.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Round Up | USD | 1 | 0001641172-25-010345 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20250331 | Temporary Equity Shares Authorized | 100000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Temporary Equity Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | -12821.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | 280500.0000 | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
0001641172-25-010345 | 20250331 | Amortization Of Intangible Assets | 42182.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Assets Noncurrent | 347959.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Common Stock Shares Issued | 678002.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Depreciation | 43221.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Depreciation And Amortization | 85409.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 8137.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Fair Value Adjustment Of Warrants | -10039.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250131 | Fair Value Adjustment Of Warrants | 147564.0000 | USD | 0 | us-gaap/2024 | Class Of Warrant Or Right= Placement Agent Warrants; | ||
0001641172-25-010345 | 20250331 | General And Administrative Expense | 1360138.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Interest Income Expense Net | 696.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Interest Income Expense Net | 2.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Interest Paid Net | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Issuance Of Common Shares For Deferred Offering Costs | USD | 1 | 0001641172-25-010345 | ||||
0001641172-25-010345 | 20241231 | Liabilities And Stockholders Equity | 3082543.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Noncash Issuance Of Vested Shares | USD | 1 | 0001641172-25-010345 | ||||
0001641172-25-010345 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 17906.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001641172-25-010345 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001641172-25-010345 | 20250331 | Other Income | 2565.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Prepaid Expense And Other Assets Current | 493558.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Proceeds From Issuance Of Common Stock | 2307707.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants | 1817640.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Proceeds From Issuance Of Warrants | 4373870.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20231231 | Stockholders Equity | -96499518.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001641172-25-010345 | 20240331 | Stockholders Equity | 105985269.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Stockholders Equity | 112750472.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Shares Issuance Of Common Shares For Vested Restricted Stock Units | 14586.0000 | shares | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250131 | Stock Issued During Period Shares New Issues | 1229330.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | USD | 1 | 0001641172-25-010345 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | USD | 1 | 0001641172-25-010345 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | 322453.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issued For Services | 75044.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issued For Services | 70421.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issued For Services | 4623.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Other | -469.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Round Up | USD | 1 | 0001641172-25-010345 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20241231 | Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 266764.0000 | shares | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 193848.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20241231 | Assets | 3082543.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Assets Current | 2734584.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4294435.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 4068059.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Common Stock Shares Outstanding | 2471656.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Earnings Per Share Basic | -1.2200 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Finite Lived Intangible Assets Net | 42182.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Gain Loss On Investments | 11398.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Income Tax Expense Benefit | 1731.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Increase Decrease In Due To Related Parties | -131516.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 46126.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Issuance Of Common Shares For Deferred Offering Costs | 322453.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20240331 | Net Cash Provided By Used In Operating Activities | -2598347.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001641172-25-010345 | 20250331 | Net Income Loss | -2184966.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001641172-25-010345 | 20250331 | Net Offering Costs | 755487.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20250331 | Offering Costs Accrued Not Paid | 129403.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20241231 | Other Income | 20000.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Other Liabilities Current | 232891.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
0001641172-25-010345 | 20240331 | Payments Of Stock Issuance Costs | 144058.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Prepaid Expense And Other Assets Current | 540405.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Property Plant And Equipment Net | 267279.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Retained Earnings Accumulated Deficit | -108259471.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Share Based Compensation | 351488.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Shares Outstanding | 678002.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20241231 | Stockholders Equity | -594517.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001641172-25-010345 | 20241231 | Stockholders Equity | -106074505.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001641172-25-010345 | 20250331 | Stockholders Equity | -598004.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Shares Common Stock Sold Under Equity Distribution | 111200.0000 | shares | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250131 | Stock Issued During Period Shares New Issues | 437336.0000 | shares | 0 | us-gaap/2024 | Class Of Warrant Or Right= Prefunded Warrants; | ||
0001641172-25-010345 | 20250131 | Stock Issued During Period Shares New Issues | 1666666.0000 | shares | 0 | us-gaap/2024 | Class Of Warrant Or Right= Series A Warrants; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Shares Other | 46934.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | USD | 1 | 0001641172-25-010345 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | 2676980.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | 2675677.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Accounts Payable Current | 669194.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 351488.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 351488.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20241231 | Cash | 2241026.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2241026.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Common Stock Equity Distribution Costs | 583713.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20241231 | Common Stock Value | 6780.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Common Stock Value | 24716.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -3923.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | General And Administrative Expense | 1885753.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Income Taxes Paid Net | 24001.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Net Cash Provided By Used In Financing Activities | 4448914.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Offering Costs Accrued Not Paid | 49249.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -3487.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001641172-25-010345 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20231231 | Shares Outstanding | 182625.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stockholders Equity | 6481856.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Stockholders Equity | 4863.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stockholders Equity | 24716.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Shares Round Up | 87402.0000 | shares | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | 1807677.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | USD | 1 | 0001641172-25-010345 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | USD | 1 | 0001641172-25-010345 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | 1303.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | 146.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value New Issues | 12293.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20241231 | Temporary Equity Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | 267679.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 6356036.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Depreciation And Amortization | 81024.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Earnings Per Share Basic | -9.2100 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2455184.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -301281.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Liabilities Current | 1489736.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20240331 | Net Cash Provided By Used In Financing Activities | 6658269.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Net Income Loss | -2184966.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001641172-25-010345 | 20250331 | Noncash Issuance Of Vested Shares | 146.0000 | USD | 1 | 0001641172-25-010345 | |||
0001641172-25-010345 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -3487.0000 | USD | 1 | us-gaap/2024 | |||
0001641172-25-010345 | 20250331 | Preferred Stock Shares Authorized | 3600000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
0001641172-25-010345 | 20241231 | Property Plant And Equipment Net | 305777.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Stockholders Equity | 1592807.0000 | USD | 0 | us-gaap/2024 | |||
0001641172-25-010345 | 20241231 | Stockholders Equity | 108255049.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20241231 | Stockholders Equity | 6780.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20250331 | Stockholders Equity | -108259471.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001641172-25-010345 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
0001641172-25-010345 | 20250131 | Stock Issued During Period Shares New Issues | 1666666.0000 | shares | 0 | us-gaap/2024 | Class Of Warrant Or Right= Series B Warrants; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | USD | 1 | 0001641172-25-010345 | ||||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | 152.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Common Stock; | ||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | USD | 1 | 0001641172-25-010345 | Equity Components= Retained Earnings; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001641172-25-010345 | 20240331 | Stock Issued During Period Value Other | 1537140.0000 | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Round Up | USD | 1 | 0001641172-25-010345 | ||||
0001641172-25-010345 | 20250331 | Stock Issued During Period Value Round Up | -874.0000 | USD | 1 | 0001641172-25-010345 | Equity Components= Additional Paid In Capital; | ||
0001641172-25-010345 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | USD | 0 | us-gaap/2024 | ||||
0001641172-25-010345 | 20250331 | Temporary Equity Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; | ||
0001641172-25-010345 | 20250331 | Temporary Equity Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series C Redeemable Preferred Stock; |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | 0001641172-25-010345 | 1 | 0 | monetary | D | D | Exercise of Inducement Warrants for common stock | Stock issued during period value exercise of inducement warrants for common stock. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. |
Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
Offering Costs Accrued Not Paid | 0001641172-25-010345 | 1 | 0 | monetary | D | C | Offering costs accrued not paid | Offering costs accrued not paid. |
Stock Issued During Period Value Common Stock Sold Under Equity Distribution | 0001641172-25-010345 | 1 | 0 | monetary | D | D | Common stock sold under the Equity Distribution Agreement, net of offering costs of $583,713 | Stock issued during period value common stock sold under equity distribution. |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Investments | Amount of realized and unrealized gain (loss) on investment. |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Income | Amount of revenue and income classified as other. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Stock Issued1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued | The fair value of stock issued in noncash financing activities. |
Stock Issued During Period Shares Issued For Services | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | |
Temporary Equity Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Issued | The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
Issuance Of Common Shares For Deferred Offering Costs | 0001641172-25-010345 | 1 | 0 | monetary | D | C | Issuance of common shares for offering costs | Issuance of common shares for deferred offering costs. |
Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Increase Decrease In Due To Related Parties | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Due to Related Parties | The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
Temporary Equity Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Authorized | The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Common Stock Equity Distribution Costs | 0001641172-25-010345 | 1 | 0 | monetary | D | D | Common stock equity distribution costs | Common stock equity distribution costs. |
Stock Issued During Period Shares Common Stock Sold Under Equity Distribution | 0001641172-25-010345 | 1 | 0 | shares | D | Common stock sold under the Equity Distribution Agreement, net of offering cost, shares | Stock issued during period shares common stock sold under equity distribution. | |
Stock Issued During Period Value Round Up | 0001641172-25-010345 | 1 | 0 | monetary | D | C | Issuance of round up shares | Issuance of round up shares, value. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Stock Issued During Period Value Issued For Services | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Temporary Equity, Par or Stated Value Per Share | Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. | |
Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants | Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholder, which takes precedence over common stockholders in the event of liquidation and from issuance of rights to purchase common shares at a predetermined price. |
Temporary Equity Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Outstanding | The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
Accounts Payable And Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. |
Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
Interest Income Expense Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Operating | Amount of interest income (expense) classified as operating. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Stock Issued During Period Shares Other | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
Noncash Issuance Of Vested Shares | 0001641172-25-010345 | 1 | 0 | monetary | D | C | Non-cash issuance of RSA vested shares | Non-cash issuance of RSA vested shares. |
Stock Issued During Period Shares Issued Direct Offering Net Of Offering Cost | 0001641172-25-010345 | 1 | 0 | shares | D | Issuance of direct offering shares, shares | Stock issued during period shares issued direct offering net of offering cost. | |
Stock Issued During Period Shares Round Up | 0001641172-25-010345 | 1 | 0 | shares | D | Issuance of round up shares, shares | Issuance of round up shares. | |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Stock Issued During Period Shares Exercise Of Inducement Warrants For Common Stock | 0001641172-25-010345 | 1 | 0 | monetary | D | D | Exercise of Inducement Warrants for common stock, shares | Stock issued during period shares exercise of inducement warrants for common stock. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Proceeds From Issuance Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Warrants | The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | 0001641172-25-010345 | 1 | 0 | monetary | D | C | Issuance of common shares for vested RSAs | Stock issued during period value issuance of common shares for vested restricted stock units. |
Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Fair Value Adjustment Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | 0001641172-25-010345 | 1 | 0 | monetary | D | C | Issuance of direct offering shares | Stock issued during period value issued direct offering net of offering cost. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests | Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
Net Offering Costs | 0001641172-25-010345 | 1 | 0 | monetary | D | D | Net offering costs | Net offering costs. |
Stock Issued During Period Shares Issuance Of Common Shares For Vested Restricted Stock Units | 0001641172-25-010345 | 1 | 0 | shares | D | Issuance of common shares for vested RSU, shares | Stock issued during period shares issuance of common shares for vested restricted stock units. | |
Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001641172-25-010345 | 2 | 8 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
0001641172-25-010345 | 2 | 9 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
0001641172-25-010345 | 2 | 10 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0001641172-25-010345 | 2 | 12 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0001641172-25-010345 | 2 | 13 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | Intangible assets, net | 0 |
0001641172-25-010345 | 2 | 14 | BS | 0 | H | Assets Noncurrent | us-gaap/2024 | Total other assets | 0 |
0001641172-25-010345 | 2 | 15 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0001641172-25-010345 | 2 | 18 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
0001641172-25-010345 | 2 | 19 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Due to related parties | 0 |
0001641172-25-010345 | 2 | 20 | BS | 0 | H | Accounts Payable And Other Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
0001641172-25-010345 | 2 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0001641172-25-010345 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 9) | 0 |
0001641172-25-010345 | 2 | 24 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
0001641172-25-010345 | 2 | 25 | BS | 0 | H | Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | us-gaap/2024 | Total mezzanine equity | 0 |
0001641172-25-010345 | 2 | 27 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
0001641172-25-010345 | 2 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.01 par value, 100,000,000 shares authorized, 2,471,656 and 678,002 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
0001641172-25-010345 | 2 | 29 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
0001641172-25-010345 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0001641172-25-010345 | 2 | 31 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
0001641172-25-010345 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders equity | 0 |
0001641172-25-010345 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities, mezzanine equity, and shareholders equity | 0 |
0001641172-25-010345 | 3 | 9 | BS | 1 | H | Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | Temporary equity, par value | 0 |
0001641172-25-010345 | 3 | 10 | BS | 1 | H | Temporary Equity Shares Authorized | us-gaap/2024 | Temporary equity, shares authorized | 0 |
0001641172-25-010345 | 3 | 11 | BS | 1 | H | Temporary Equity Shares Issued | us-gaap/2024 | Temporary equity, shares issued | 0 |
0001641172-25-010345 | 3 | 12 | BS | 1 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Temporary equity, shares outstanding | 0 |
0001641172-25-010345 | 3 | 13 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
0001641172-25-010345 | 3 | 14 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
0001641172-25-010345 | 3 | 15 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
0001641172-25-010345 | 3 | 16 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
0001641172-25-010345 | 3 | 17 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
0001641172-25-010345 | 3 | 18 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0001641172-25-010345 | 3 | 19 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
0001641172-25-010345 | 3 | 20 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
0001641172-25-010345 | 4 | 2 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
0001641172-25-010345 | 4 | 3 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
0001641172-25-010345 | 4 | 4 | IS | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
0001641172-25-010345 | 4 | 5 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
0001641172-25-010345 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0001641172-25-010345 | 4 | 8 | IS | 0 | H | Other Income | us-gaap/2024 | Other income | 0 |
0001641172-25-010345 | 4 | 9 | IS | 0 | H | Interest Income Expense Net | us-gaap/2024 | Interest income, net | 0 |
0001641172-25-010345 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income | 0 |
0001641172-25-010345 | 4 | 11 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net loss before income taxes | 0 |
0001641172-25-010345 | 4 | 12 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 1 |
0001641172-25-010345 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001641172-25-010345 | 4 | 15 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation | 0 |
0001641172-25-010345 | 4 | 16 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
0001641172-25-010345 | 4 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share - basic | 0 |
0001641172-25-010345 | 4 | 18 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share - diluted | 0 |
0001641172-25-010345 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding, basic | 0 |
0001641172-25-010345 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding, diluted | 0 |
0001641172-25-010345 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
0001641172-25-010345 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
0001641172-25-010345 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487 | 0 |
0001641172-25-010345 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock and Series A and B and prefunded warrants for cash, net of offering costs, shares | 0 |
0001641172-25-010345 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Issuance Of Common Shares For Vested Restricted Stock Units | 0001641172-25-010345 | Issuance of common shares for vested RSAs | 0 |
0001641172-25-010345 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Issuance Of Common Shares For Vested Restricted Stock Units | 0001641172-25-010345 | Issuance of common shares for vested RSU, shares | 0 |
0001641172-25-010345 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2024 | Issuance of common shares for exercise of warrants | 0 |
0001641172-25-010345 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Issued For Services | us-gaap/2024 | Issuance of common shares for exercise of warrants, shares | 0 |
0001641172-25-010345 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Round Up | 0001641172-25-010345 | Issuance of round up shares | 0 |
0001641172-25-010345 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Round Up | 0001641172-25-010345 | Issuance of round up shares, shares | 0 |
0001641172-25-010345 | 5 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock based compensation | 0 |
0001641172-25-010345 | 5 | 21 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign exchange translation gain | 0 |
0001641172-25-010345 | 5 | 22 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001641172-25-010345 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Value Common Stock Sold Under Equity Distribution | 0001641172-25-010345 | Common stock sold under the Equity Distribution Agreement, net of offering costs of $583,713 | 0 |
0001641172-25-010345 | 5 | 24 | EQ | 0 | H | Stock Issued During Period Shares Common Stock Sold Under Equity Distribution | 0001641172-25-010345 | Common stock sold under the Equity Distribution Agreement, net of offering cost, shares | 0 |
0001641172-25-010345 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Value Issued Direct Offering Net Of Offering Cost | 0001641172-25-010345 | Issuance of direct offering shares | 0 |
0001641172-25-010345 | 5 | 26 | EQ | 0 | H | Stock Issued During Period Shares Issued Direct Offering Net Of Offering Cost | 0001641172-25-010345 | Issuance of direct offering shares, shares | 0 |
0001641172-25-010345 | 5 | 27 | EQ | 0 | H | Stock Issued During Period Value Exercise Of Inducement Warrants For Common Stock | 0001641172-25-010345 | Exercise of Inducement Warrants for common stock | 0 |
0001641172-25-010345 | 5 | 28 | EQ | 0 | H | Stock Issued During Period Shares Exercise Of Inducement Warrants For Common Stock | 0001641172-25-010345 | Exercise of Inducement Warrants for common stock, shares | 0 |
0001641172-25-010345 | 5 | 29 | EQ | 0 | H | Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | Proceeds from the subscription receivable related to the issuance of Inducement Warrants, net of offering costs of $12,821 | 0 |
0001641172-25-010345 | 5 | 30 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance | 0 |
0001641172-25-010345 | 5 | 31 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance, shares | 0 |
0001641172-25-010345 | 5 | 32 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
0001641172-25-010345 | 5 | 33 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
0001641172-25-010345 | 6 | 1 | EQ | 1 | H | Net Offering Costs | 0001641172-25-010345 | Net offering costs | 0 |
0001641172-25-010345 | 6 | 2 | EQ | 1 | H | Common Stock Equity Distribution Costs | 0001641172-25-010345 | Common stock equity distribution costs | 0 |
0001641172-25-010345 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001641172-25-010345 | 7 | 4 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Change in fair value of warrant liability | 0 |
0001641172-25-010345 | 7 | 5 | CF | 0 | H | Gain Loss On Investments | us-gaap/2024 | Change in fair value of investment option liability | 1 |
0001641172-25-010345 | 7 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
0001641172-25-010345 | 7 | 7 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangibles | 0 |
0001641172-25-010345 | 7 | 8 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
0001641172-25-010345 | 7 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
0001641172-25-010345 | 7 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable, accrued expenses and other current liabilities | 0 |
0001641172-25-010345 | 7 | 12 | CF | 0 | H | Increase Decrease In Due To Related Parties | us-gaap/2024 | Due to related parties | 0 |
0001641172-25-010345 | 7 | 13 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
0001641172-25-010345 | 7 | 15 | CF | 0 | H | Proceeds From Issuance Of Warrants | us-gaap/2024 | Proceeds from sale of common stock and warrants, net of offering costs | 0 |
0001641172-25-010345 | 7 | 16 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from the exercise of warrants | 0 |
0001641172-25-010345 | 7 | 17 | CF | 0 | H | Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants | us-gaap/2024 | Proceeds from the subscription receivable related to the issuance of Inducement Warrants and the exercise of warrants and preferred investment options | 0 |
0001641172-25-010345 | 7 | 18 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from common stock sold under the Equity Distribution Agreement, net of offering costs | 0 |
0001641172-25-010345 | 7 | 19 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payment for offering costs previously accrued | 1 |
0001641172-25-010345 | 7 | 20 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
0001641172-25-010345 | 7 | 21 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of foreign exchange rate on changes on cash | 0 |
0001641172-25-010345 | 7 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase in cash | 0 |
0001641172-25-010345 | 7 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash at beginning of period | 0 |
0001641172-25-010345 | 7 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash at end of period | 0 |
0001641172-25-010345 | 7 | 26 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
0001641172-25-010345 | 7 | 27 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Income taxes paid | 0 |
0001641172-25-010345 | 7 | 29 | CF | 0 | H | Stock Issued1 | us-gaap/2024 | Non-cash issuance of round-up shares | 0 |
0001641172-25-010345 | 7 | 30 | CF | 0 | H | Noncash Issuance Of Vested Shares | 0001641172-25-010345 | Non-cash issuance of RSA vested shares | 0 |
0001641172-25-010345 | 7 | 31 | CF | 0 | H | Offering Costs Accrued Not Paid | 0001641172-25-010345 | Offering costs accrued not paid | 0 |
0001641172-25-010345 | 7 | 32 | CF | 0 | H | Issuance Of Common Shares For Deferred Offering Costs | 0001641172-25-010345 | Issuance of common shares for offering costs | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |